What is BWS Financial’s Estimate for TriMas FY2024 Earnings?

TriMas Co. (NASDAQ:TRS) – Equities research analysts at BWS Financial cut their FY2024 earnings estimates for shares of TriMas in a note issued to investors on Tuesday, November 5th. BWS Financial analyst H. Khorsand now expects that the industrial products company will earn $1.67 per share for the year, down from their previous forecast of $1.70. BWS Financial currently has a “Buy” rating and a $40.00 target price on the stock. The consensus estimate for TriMas’ current full-year earnings is $1.75 per share. BWS Financial also issued estimates for TriMas’ Q1 2025 earnings at $0.43 EPS, Q2 2025 earnings at $0.52 EPS, Q3 2025 earnings at $0.59 EPS, Q4 2025 earnings at $0.44 EPS and FY2025 earnings at $1.97 EPS.

Separately, StockNews.com lowered shares of TriMas from a “hold” rating to a “sell” rating in a research report on Tuesday.

TriMas Price Performance

TRS opened at $27.39 on Friday. The firm has a market cap of $1.11 billion, a P/E ratio of 42.80 and a beta of 0.66. The firm has a 50-day moving average of $25.95 and a 200 day moving average of $25.84. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.48 and a current ratio of 2.83. TriMas has a fifty-two week low of $22.45 and a fifty-two week high of $28.51.

TriMas (NASDAQ:TRS) last posted its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.14). The company had revenue of $229.36 million for the quarter, compared to the consensus estimate of $239.33 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. TriMas’s quarterly revenue was down 2.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.57 EPS.

Hedge Funds Weigh In On TriMas

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Innealta Capital LLC bought a new position in TriMas during the second quarter worth about $26,000. Quantbot Technologies LP lifted its holdings in shares of TriMas by 5.7% in the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock worth $239,000 after buying an additional 478 shares in the last quarter. Aristides Capital LLC purchased a new stake in shares of TriMas in the second quarter worth about $245,000. Algert Global LLC lifted its holdings in shares of TriMas by 4.2% in the second quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock worth $403,000 after buying an additional 639 shares in the last quarter. Finally, Inspire Investing LLC lifted its holdings in shares of TriMas by 17.4% in the third quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company’s stock worth $412,000 after buying an additional 2,389 shares in the last quarter. Institutional investors own 99.42% of the company’s stock.

TriMas Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th will be given a dividend of $0.04 per share. The ex-dividend date is Tuesday, November 5th. This represents a $0.16 dividend on an annualized basis and a yield of 0.58%. TriMas’s dividend payout ratio is presently 25.00%.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.